U-Blot® Research Grade Anti-Human EGFR/ERBB1/HER1 (BB 1705)Cat. No. WA1876Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human EGFR/ERBB1/HER1 (BB 1705)Cat. No. WA1876
U-Blot® Research Grade Anti-Human EGFR/ERBB1/HER1 (AVID300)Cat. No. WA1875
U-Blot® Research Grade Anti-Human EGFR/ERBB1/HER1 (AVID100)Cat. No. WA1874
U-Blot® Research Grade Anti-Human EGFR/ERBB1/HER1 (ABP 494)Cat. No. WA1873
U-Blot® Research Grade Anti-Human EGFR/ERBB1/HER1 (7A7)Cat. No. WA1872
U-Blot® Research Grade Anti-Human EGFR/ERBB1/HER1 & CD16a/FCGR3A Antibody (AFM24)Cat. No. WA1871
U-Blot® Research Grade Anti-Human EDNRB/ETRB Antibody (DEDN6526A)Cat. No. WA1870
U-Blot® Research Grade Anti-Human DLL4 Antibody (MLCK-2ABL-001)Cat. No. WA1869
U-Blot® Research Grade Anti-Human DLL4 (MEDI0639)Cat. No. WA1868
U-Blot® Research Grade Anti-Human DLL3 (AMG 119)Cat. No. WA1867
U-Blot® Research Grade Anti-Human DLL3 & CD47/MER6 Antibody (PT-217)Cat. No. WA1866
U-Blot® Research Grade Anti-Human DLK1 Antibody (LIV-1205)Cat. No. WA1865